B

Baroness Merron (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

We have invested in new research just this year to build on workplace support for nurses and midwives who are working in health and social care during menopause. We are also looking at improving quality of life, particularly where there are disparities in ethnicity in respect of HRT use and particularly in older women, who may also be unaware of and excluded from the support available. These ongoing studies will assist us to make it more widely available.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.